Tech Company Financing Transactions

Geneoscopy Funding Round

On 11/18/2021, Geneoscopy raised $105 million in Series B funding from Lightchain, NT Investments and BioGenerator.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Healthcare Services

Mailing Address

20 S Sarah St.
St. Louis, MO 63108
USA

Phone

Undisclosed

Website

www.geneoscopy.com

Email Address

[email protected]

Overview

Geneoscopy is a non-invasive colorectal cancer diagnostic powered by advanced research in computational biology. The company is determined to replace every patient's least favorite screen: the colonoscopy. Currently there is no test with high enough specificity and sensitivity to allow patients an alternative to the unpleasant, invasive colonoscopy. Geneoscopy is changing that.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Andrew Barnell

        

Browse more venture capital transactions:

Prev: 11/18/2021: Luxury Presence venture capital transaction
Next: 11/18/2021: Velocity India venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to record every notable VC transaction. VC transactions on this site are derived from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary